Gene Expression Profiling of Post Mortem Midbrain of Parkinson’s Disease Patients and Healthy Controls
Authors:
- Michele SalemiMSMichele Salemi
- Maria RavoMRMaria Ravo
- Giuseppe LanzaGiuseppe Lanza
- Francesca A. SchillaciFrancesca A. Schillaci
- Giovanna Maria VentolaGVGiovanna Maria Ventola
- Giovanna MarcheseGMGiovanna Marchese
- Maria Grazia SalluzzoMSMaria Grazia Salluzzo
- Graziella CappellettiGCGraziella Cappelletti
- Raffaele FerriRFRaffaele Ferri
Open Access
- 5 January 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 707
Abstract
Parkinson’s disease (PD) stands as the most prevalent degenerative movement disorder, marked by the degeneration of dopaminergic neurons in the substantia nigra of the midbrain. In this study, we conducted a transcriptome analysis utilizing post mortem mRNA extracted from the substantia nigra of both PD patients and healthy control (CTRL) individuals. Specifically, we acquired eight samples from individuals with PD and six samples from CTRL individuals, with no discernible pathology detected in the latter group. RNA sequencing was conducted using the TapeStation 4200 system from Agilent Technologies. A total of 16,148 transcripts were identified, with 92 mRNAs displaying differential expression between the PD and control groups. Specifically, 33 mRNAs were significantly up-regulated, while 59 mRNAs were down-regulated in PD compared to the controls. The identification of statistically significant signaling pathways, with an adjusted p-value threshold of 0.05, unveiled noteworthy insights. Specifically, the enriched categories included cardiac muscle contraction (involving genes such as ATPase Na+/K+ transporting subunit beta 2 (ATP1B2), solute carrier family 8 member A1 (SLC8A1), and cytochrome c oxidase subunit II (COX2)), GABAergic synapse (involving GABA type A receptor-associated protein-like 1 (GABARAPL1), G protein subunit beta 5 (GNB5), and solute carrier family 38 member 2 (SLC38A2), autophagy (involving GABARAPL1 and tumor protein p53-inducible nuclear protein 2 (TP53INP2)), and Fc gamma receptor (FcγR) mediated phagocytosis (involving amphiphysin (AMPH)). These findings uncover new pathophysiological dimensions underlying PD, implicating genes associated with heart muscle contraction. This knowledge enhances diagnostic accuracy and contributes to the advancement of targeted therapies.Keywords
All Related Versions
Funding Information
- Italian Ministry of Health (RC-2779777)
This publication has 85 references indexed in Scilit:
- Specific Distribution of the Autophagic Protein GABARAPL1/GEC1 in the Developing and Adult Mouse Brain and Identification of Neuronal Populations Expressing GABARAPL1/GEC1PLOS ONE, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Mitochondrial Quality Control and Dynamics in Parkinson's DiseaseAntioxidants & Redox Signaling, 2012
- Mitochondria in Neurodegeneration2011
- N-myc Downstream-regulated Gene 2, a Novel Estrogen-targeted Gene, Is Involved in the Regulation of Na+/K+-ATPaseJournal of Biological Chemistry, 2011
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- Involvement of Fc Receptors in Disorders of the Central Nervous SystemNeuroMolecular Medicine, 2009
- Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathologyBrain, 2008
- Complex I deficiency in Parkinson's disease frontal cortexBrain Research, 2008
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991